Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Christian

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Nature Immunology|April 19, 2022
PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infectionJoseph A Perry, Lindsey Shallberg, Joseph T Clark, et al.
Mucosal Immunology|March 20, 2024
Dendritic cell-mediated responses to secreted Cryptosporidium effectors promote parasite-specific CD8<sup>+</sup> T cell responsesBreanne E Haskins, Jodi A Gullicksrud, Bethan A Wallbank, et al.
The Journal of Clinical Investigation|August 30, 2016
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapiesMarco Ruella, David M Barrett, Saad S Kenderian, et al.
Nature Medicine|April 23, 2021
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cellsNathan Singh, Noelle V Frey, Boris Engels, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Nature Immunology|April 19, 2022
PD-L1-PD-1 interactions limit effector regulatory T cell populations at homeostasis and during infectionJoseph A Perry, Lindsey Shallberg, Joseph T Clark, et al.
Mucosal Immunology|March 20, 2024
Dendritic cell-mediated responses to secreted Cryptosporidium effectors promote parasite-specific CD8<sup>+</sup> T cell responsesBreanne E Haskins, Jodi A Gullicksrud, Bethan A Wallbank, et al.
The Journal of Clinical Investigation|August 30, 2016
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapiesMarco Ruella, David M Barrett, Saad S Kenderian, et al.
Nature Medicine|April 23, 2021
Antigen-independent activation enhances the efficacy of 4-1BB-costimulated CD22 CAR T cellsNathan Singh, Noelle V Frey, Boris Engels, et al.
Pageof 6